Published in PLoS One on September 02, 2015
sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides. Sci Rep (2016) 0.75
Partial Dissociation of Truncated Peptides Influences the Structural Dynamics of the MHCI Binding Groove. Front Immunol (2017) 0.75
Prediction of peptide binding to a major histocompatibility complex class I molecule based on docking simulation. J Comput Aided Mol Des (2016) 0.75
Histocompatibility-linked immune response genes. Science (1972) 16.79
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem (2003) 15.88
Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol (1989) 8.84
How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 7.57
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. J Chem Theory Comput (2011) 3.98
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet (2010) 3.24
Consistent treatment of inter- and intramolecular polarization in molecular mechanics calculations. J Comput Chem (2002) 3.11
Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol (1982) 2.51
Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci U S A (1997) 2.10
Nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci U S A (1988) 2.05
HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum (2009) 2.00
Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant (2007) 1.60
New insights into the pathogenesis of Behçet's disease. Autoimmun Rev (2011) 1.60
Mortality in Behçet's disease. Arthritis Rheum (2010) 1.53
Behçet's disease. Best Pract Res Clin Rheumatol (2004) 1.41
Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol (2001) 1.41
Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet (2013) 1.34
Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. J Mol Biol (1999) 1.10
A strong association between HLA-B*5101 and Behçet's disease in Greek patients. Tissue Antigens (1997) 1.06
HSP 60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol (2001) 1.05
Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J Immunol (2000) 1.04
Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J (1997) 1.04
Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens (2006) 1.03
MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors. PLoS Pathog (2010) 0.99
Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. Am J Ophthalmol (1993) 0.97
Evolution of human receptor binding affinity of H1N1 hemagglutinins from 1918 to 2009 pandemic influenza A virus. J Chem Inf Model (2010) 0.97
Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum (1999) 0.96
High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide. Acta Crystallogr D Biol Crystallogr (2005) 0.95
Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. Arthritis Rheum (2004) 0.95
Immunopathogenesis of Behçet's disease. Ann Med Interne (Paris) (1999) 0.94
Genetic association of HLA-A*2601 with ocular Behçet's disease in Japanese patients. Clin Exp Rheumatol (2010) 0.93
MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics (1999) 0.93
[Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments]. J Formos Med Assoc (1990) 0.93
Association of Major Histocompatibility Complex Class I Chain-Related Gene A and HLA-B Alleles with Behçet's Disease in Turkey. Jpn J Ophthalmol (2007) 0.93
Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis. PLoS One (2012) 0.92
Behçet's disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm (1999) 0.92
Normal-mode-analysis-monitored energy minimization procedure for generating small-molecule bound conformations. PLoS One (2007) 0.90
Genetics of Behçet's Disease. Patholog Res Int (2011) 0.89
Molecular insight into the specific binding of ADP-ribose to the nsP3 macro domains of chikungunya and Venezuelan equine encephalitis viruses: molecular dynamics simulations and free energy calculations. J Mol Graph Model (2010) 0.88
Source of high pathogenicity of an avian influenza virus H5N1: why H5 is better cleaved by furin. Biophys J (2008) 0.86
Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Transplantation (2009) 0.85
Structural diversity in the HLA-A10 family of alleles: correlations with serology. Tissue Antigens (1993) 0.84
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough. Front Immunol (2013) 0.84
Associations between the HLA-A polymorphism and the clinical manifestations of Behcet's disease. Arthritis Res Ther (2011) 0.83
Post-transplant soluble MICA and MICA antibodies predict subsequent heart graft outcome. Transpl Immunol (2006) 0.81
The HLA-B*5101 molecule-binding capacity to antigens used in animal models of Behçet's disease: a bioinformatics study. Isr Med Assoc J (2012) 0.80
Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease. Graefes Arch Clin Exp Ophthalmol (2009) 0.79